Hengrui Medicine’s Innovative Drug Revenue Accounts for Nearly Sixty Percent, BD Restructuring Internationalization Anchor Value
March 25, 2026 — 22:25 CST
This Data Is Locked!
This area is available only to Subscribers.
Hengrui Medicine, a leader in the industry that started with generic drugs, has essentially completed the transformation from "combination of imitation and innovation" to 'innovation-led'.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
